Cargando…
Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT)
This prospective Phase II single-arm study gathered data on the use of intensity-modulated radiotherapy (IMRT) to deliver accelerated partial breast irradiation (APBI). Four-year efficacy, cosmesis, and toxicity results are presented. Between February 2004 and September 2007, 136 consecutive patient...
Autores principales: | Lei, Rachel Y., Leonard, Charles E., Howell, Kathryn T., Henkenberns, Phyllis L., Johnson, Timothy K., Hobart, Tracy L., Fryman, Shannon P., Kercher, Jane M., Widner, Jodi L., Kaske, Terese, Carter, Dennis L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706719/ https://www.ncbi.nlm.nih.gov/pubmed/23824363 http://dx.doi.org/10.1007/s10549-013-2623-x |
Ejemplares similares
-
External Beam Accelerated Partial Breast Irradiation Yields Favorable Outcomes in Patients with Prior Breast Augmentation
por: Lei, Rachel Y., et al.
Publicado: (2014) -
A prospective Phase III trial evaluating patient self‐reported pain and cosmesis in accelerated partial breast irradiation utilizing 3‐D versus intensity‐modulated radiotherapy
por: Leonard, Charles E., et al.
Publicado: (2021) -
Does the Presence of Cytokeratin Positive Individual Tumor Cells (N(0(I+))) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation
por: Smith, Jamie, et al.
Publicado: (2021) -
Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
por: Jacobs, D. H. M., et al.
Publicado: (2018) -
Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other “High Risk” Variables Categorized as Cautionary in The ASTRO Guidelines
por: Goulding, Anabel, et al.
Publicado: (2021)